BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on BIONTECH SE
05/17UBS Adjusts BioNTech Price Target to $168 From $170, Maintains Neutral Rating
MT
05/11BIONTECH : Goldman Sachs sticks Neutral
MD
05/10Morgan Stanley Lowers BioNTech SE's Price Target to $195 From $197, Equalweight Rating ..
MT
05/09BIONTECH : JP Morgan reiterates its Neutral rating
MD
05/09BIONTECH : Jefferies reiterates its Neutral rating
MD
04/12HC Wainwright Adjusts BioNTech's Price Target to $298 from $339, Keeps Buy Rating Ratin..
MT
04/12Morgan Stanley Adjusts BioNTech's Price Target to $197 from $217, Keeps Equalweight Rat..
MT
04/11BIONTECH : Berenberg reiterates its Buy rating
MD
04/11Berenberg Bank Adjusts BioNTech's Price Target to $350 From $400, Maintains Buy Rating
MT
04/05Canaccord Genuity Adjusts Price Target on BioNTech to $300 From $450, Reiterates Buy Ra..
MT
04/04BIONTECH : Berenberg reiterates its Buy rating
MD
04/01BIONTECH : Goldman Sachs reiterates its Neutral rating
MD
04/01BIONTECH : Deutsche Bank gives a Neutral rating
MD
03/31BIONTECH : JP Morgan sticks Neutral
MD
03/30BIONTECH : Jefferies reaffirms its Neutral rating
MD
03/18BIONTECH : Jefferies remains Neutral
MD
02/23HC Wainwright Adjusts BioNTech's Price Target to $339 from $366, Maintains Buy Rating
MT
02/01Morgan Stanley Adjusts BioNTech's Price Target to $217 From $284, Keeps Equalweight Rat..
MT
02/01Redburn Upgrades BioNTech to Neutral From Sell
MT
01/21UBS Adjusts BioNTech SE Price Target to $170 From $300, Maintains Neutral Rating
MT
01/19BIONTECH : Goldman Sachs sticks Neutral
MD
01/18Morgan Stanley Adjusts BioNTech's Price Target to $284 from $294, Keeps Equalweight Rat..
MT
01/12BIONTECH : Goldman Sachs reaffirms its Neutral rating
MD
01/05BIONTECH : Receives a Buy rating from Berenberg
MD
2021Kempen Upgrades BioNTech SE to Buy From Neutral, Adjust Price Target to $350 From $300
MT
2021HC Wainwright Adjusts BioNTech's Price Target to $366 From $360, Keeps Buy Rating
MT
2021BIONTECH : From a Buy to Neutral rating by Morgan Stanley
MD
2021Morgan Stanley Starts BioNTech at Equalweight with $294 Price Target
MT
2021ANALYST RECOMMENDATIONS : AT&T, BioNTech, Columbia Sports, Jefferies, Under Armour...
2021BIONTECH : Deutsche Bank gives a Neutral rating
MD
2021BIONTECH : Berenberg reiterates its Buy rating
MD
2021BIONTECH : Jefferies remains Neutral
MD
2021BIONTECH : Jefferies remains Neutral
MD
2021BofA Securities Adjusts Price Target on BioNTech SE to $349 From $341, Maintains Neutra..
MT
2021BIONTECH : Berenberg reiterates its Buy rating
MD
2021BIONTECH : Jefferies sticks Neutral
MD
2021HC Wainwright Upgrades BioNTech SE to Buy from Neutral
MT
2021JPMorgan Adjusts Price Target for BioNTech SE to $180 From $153, Maintains Neutral Rati..
MT
2021BIONTECH : JP Morgan remains Neutral
MD
2021BIONTECH : Jefferies sticks Neutral
MD
2021BIONTECH : Deutsche Bank Starts BioNTech at Hold with $250 Price Target
MT
2021BIONTECH : Jefferies Starts BioNTech at Hold With $230 Price Target
MT
2021BIONTECH : Jefferies reaffirms its Neutral rating
MD
2021BIONTECH : SVB Leerink Adjusts Price Target on BioNTech to $268 From $293, Maintains Marke..
MT
2021BIONTECH : Berenberg reiterates its Buy rating
MD
2021BIONTECH : Receives a Buy rating from Bryan Garnier
MD
2021BIONTECH : Kempen Downgrades BioNTech SE to Neutral From Buy, Lifts Price Target to $300 F..
MT
2021BIONTECH : Receives a Buy rating from Bryan Garnier
MD
2021BIONTECH : Goldman Sachs reiterates its Neutral rating
MD
2021BIONTECH : UBS remains Neutral
MD
2021BIONTECH : UBS Adjusts Price Target on BioNTech to $300 From $111, Maintains Neutral Ratin..
MT
2021BIONTECH : Canaccord Genuity Adjusts BioNTech's Price Target to $450 From $240, Keeps Buy ..
MT
2021BIONTECH : SVB Leerink Adjusts Price Target on BioNTech to $293 From $159, Maintains Marke..
MT
2021BIONTECH : Goldman Sachs Adjusts Price Target on BioNTech to $433 From $173, Maintains Neu..
MT
2021BIONTECH : Bryan Garnier Upgrades BioNTech to Buy From Neutral; Price Target is $451
MT
2021BIONTECH : HC Wainwright Adjusts BioNTech's Price Target to $330 From $194, Maintains Neut..
MT
2021ANALYST RECOMMENDATIONS : Callaway, Flutter, Qualys, Synaptics, Virgin Galactic...
2021BIONTECH : Goldman Sachs sticks Neutral
MD
2021BIONTECH : Berenberg reiterates its Buy rating
MD
2021BIONTECH : Berenberg Bank Adjusts BioNTech PT to $400 From $235, Maintains Buy Rating
MT
2021BIONTECH : Wolfe Research Assumes Coverage of BioNTech With Peerperform Rating With $248 P..
MT
2021BIONTECH : Redburn Downgrades BioNTech to Sell From Neutral
MT
2021BIONTECH : Goldman Sachs gives a Neutral rating
MD
2021BIONTECH : Goldman Sachs Starts BioNTech SE at Neutral With $173 Price Target
MT
2021TODAY'S ANALYST RECOMMENDATIONS : Alibaba, BioNTech, Home Depot, Lowe's, Roblox...
2021BIONTECH : Canaccord Genuity Adjusts Price Target on BioNTech to $240 From $130, Maintains..
MT
2021BIONTECH : Berenberg Bank Adjusts BioNTech Price Target to $235 From $130 on Positive Outl..
MT
2021BIONTECH : JPMorgan Adjusts Price Target for BioNTech SE to $133 From $104, Maintains Neut..
MT
2021BIONTECH : SVB Leerink Adjusts Price Target on BioNTech to $159 From $118, Maintains Marke..
MT
2021BIONTECH : Bryan Garnier Downgrades BioNTech SE to Neutral From Buy, Adjusts Price Target ..
MT
2021BIONTECH : SVB Leerink Adjusts BioNTech PT to $118 From $110, Maintains Market Perform Rat..
MT
2021BIONTECH : SVB Leerink Adjusts Price Target on BioNTech to $110 From $106, Maintains Marke..
MT
2021BIONTECH : JP Morgan reiterates its Neutral rating
MD
2021BIONTECH : Gets a Buy rating from Berenberg
MD
2021BIONTECH : SVB Leerink Adjusts BioNTech's Price Target to $106 From $97, Keeps Market Perf..
MT
1  2Next
Upcoming event on BIONTECH SE